Article Sidebar
Published:
Oct 19, 2016Article Details
http://www.sajp.org.za/index.php/sajp/pages/view/policies#part_4
Copyright
The author(s) retain copyright on work published by AOSIS unless specified otherwise.
Licensing and publishing rights
Author(s) of work published by AOSIS are required to grant AOSIS the unlimited rights to publish the definitive work in any format, language and medium, for any lawful purpose.
AOSIS requires journal authors to publish their work in open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
Read more here: http://creativecommons.org/licenses/by/4.0/.
The authors retain the non-exclusive right to do anything they wish with the published article(s), provided attribution is given to the applicable journal with details of the original publication, as set out in the official citation of the article published in the journal. The retained right specifically includes the right to post the article on the authors’ or their institution’s websites or in institutional repositories.
Previously published work may have been published under a different licence. We advise the community that if they would like to reuse the work to consult the applicable licence at article level.
Main Article Content
Electroconvulsive therapy and its use in modern-day psychiatry
Abstract
Electroconvulsive therapy (ECT) has been regarded as a somewhat controversial treatment modality. Despite initial stigmatisation, ECT has remained with us for the past 60 years and is now emerging as a safe and effective treatment option.
ECT is indicated in a wide range of disorders and is often found to be of equal or even superior efficacy compared with currently available pharmacological agents. However, it is not without adverse effects and therefore a sound knowledge of this treatment modality is crucial before its administration. The clinician should have a thorough knowledge of indications, method of administration, patient preparation, required seizure duration, treatment course and side-effect profile.
